CANADA LIFE ASSURANCE Co
InsurancePosition in DNLI — Denali Therapeutics Inc.
CIK 1046192
WINNIPEG, A2
Position in DNLI
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$345,522
+$87,590 QoQ
Shares Held
13,434
0.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#173
of 290 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DNLI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CANADA LIFE ASSURANCE Co holds $333,087,992 across 79 Biotechnology names. DNLI ranks #49 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
182,365 | $90,586,166 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
86,761 | $54,098,953 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
69,102 | $20,801,775 | |
| 4 | INCY |
Incyte Corp
|
126,229 | $14,309,319 | |
| 5 | ARGX |
Argenx SE
|
14,868 | $13,794,084 | |
| 6 | MRNA |
Moderna, Inc.
|
152,228 | $10,660,526 | |
| 7 | RPRX |
Royalty Pharma plc
|
185,316 | $10,390,668 | |
| 8 | EXEL |
Exelixis, Inc.
|
155,922 | $8,483,716 |
All Filings in DNLI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $345,522 | 13,434 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $257,932 | 13,434 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $221,795 | 13,434 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $195,061 | 13,434 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $187,941 | 13,434 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $182,635 | 13,434 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $273,784 | 13,434 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $391,332 | 13,434 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $311,937 | 13,434 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $199,536 | 9,724 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $208,677 | 9,724 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $200,606 | 9,724 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $127,601 | 4,324 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $106,951 | 4,642 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $129,094 | 4,642 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $142,462 | 4,642 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $136,614 | 4,642 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $124,626 | 3,874 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $199,005 | 4,462 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $225,107 | 4,462 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $349,999 | 4,462 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $279,961 | 4,903 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $506,245 | 6,044 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $216,556 | 6,044 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $146,143 | 6,044 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $105,830 | 6,044 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||